POSACONAZOLE

POSACONAZOLE was reported 16564 times

These side effects are most commonly reported by patients taking POSACONAZOLE:

# Side effect Count
0 OFF LABEL USE 1706
1 DRUG INEFFECTIVE 1513
2 FEBRILE NEUTROPENIA 1099
3 PRODUCT USE IN UNAPPROVED INDICATION 1074
4 DRUG INTERACTION 1042
5 DEATH 993
6 PYREXIA 921
7 NEUTROPENIA 770
8 PNEUMONIA 698
9 THROMBOCYTOPENIA 551
10 DIARRHOEA 550
11 NAUSEA 536
12 ACUTE KIDNEY INJURY 462
13 SEPTIC SHOCK 461
14 CONDITION AGGRAVATED 449
15 FATIGUE 443
16 SEPSIS 425
17 PANCYTOPENIA 402
18 DYSPNOEA 344
19 VOMITING 343
20 ACUTE MYELOID LEUKAEMIA 321
21 ANAEMIA 320
22 DISEASE PROGRESSION 313
23 HYPOKALAEMIA 311
24 PLATELET COUNT DECREASED 306
25 INFECTION 304
26 ASTHENIA 298
27 HEADACHE 289
28 RESPIRATORY FAILURE 282
29 PRODUCT USE ISSUE 281
30 RENAL FAILURE 274
31 GRAFT VERSUS HOST DISEASE 265
32 BRONCHOPULMONARY ASPERGILLOSIS 256
33 ASPERGILLUS INFECTION 255
34 FUNGAL INFECTION 236
35 ELECTROCARDIOGRAM QT PROLONGED 235
36 HYPOTENSION 235
37 RASH 231
38 MULTIPLE ORGAN DYSFUNCTION SYNDROME 221
39 DECREASED APPETITE 217
40 TOXICITY TO VARIOUS AGENTS 205
41 WHITE BLOOD CELL COUNT DECREASED 203
42 COUGH 200
43 PNEUMONIA FUNGAL 199
44 DRUG RESISTANCE 194
45 HYPERTENSION 192
46 ABDOMINAL PAIN 190
47 MUCORMYCOSIS 187
48 CHOLESTASIS 185
49 CYTOKINE RELEASE SYNDROME 185
50 PLEURAL EFFUSION 179
51 CONSTIPATION 173
52 HAEMOGLOBIN DECREASED 170
53 RENAL IMPAIRMENT 169
54 BACTERAEMIA 168
55 PAIN 165
56 ACUTE MYELOID LEUKAEMIA RECURRENT 164
57 TREATMENT FAILURE 163
58 DIZZINESS 161
59 GENERAL PHYSICAL HEALTH DETERIORATION 160
60 COVID-19 156
61 CYTOMEGALOVIRUS INFECTION 152
62 HEPATIC CYTOLYSIS 151
63 CYTOPENIA 149
64 URINARY TRACT INFECTION 149
65 HYPOXIA 147
66 HEPATOTOXICITY 146
67 CYTOMEGALOVIRUS INFECTION REACTIVATION 145
68 STAPHYLOCOCCAL INFECTION 145
69 FALL 142
70 NEUTROPHIL COUNT DECREASED 141
71 PRODUCT DOSE OMISSION ISSUE 141
72 MYELOSUPPRESSION 140
73 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 139
74 CARDIAC ARREST 138
75 HYPERBILIRUBINAEMIA 137
76 BONE MARROW FAILURE 135
77 DEVICE RELATED INFECTION 134
78 MALAISE 134
79 WEIGHT DECREASED 134
80 ADVERSE EVENT 132
81 MUCOSAL INFLAMMATION 132
82 TACHYCARDIA 129
83 CONFUSIONAL STATE 126
84 OEDEMA PERIPHERAL 126
85 ENCEPHALOPATHY 125
86 MUSCULAR WEAKNESS 125
87 NEUROPATHY PERIPHERAL 124
88 ALANINE AMINOTRANSFERASE INCREASED 123
89 PSEUDOMONAS INFECTION 122
90 ATRIAL FIBRILLATION 120
91 DRUG-INDUCED LIVER INJURY 120
92 HYPONATRAEMIA 120
93 CANDIDA INFECTION 119
94 FUSARIUM INFECTION 118
95 HAEMORRHAGE 118
96 PRURITUS 117
97 HOSPITALISATION 116
98 CHILLS 115
99 RASH MACULO-PAPULAR 114
100 ARTHRALGIA 113
101 BLOOD CREATININE INCREASED 113
102 NEUROTOXICITY 113
103 DRUG LEVEL BELOW THERAPEUTIC 111
104 BACTERIAL INFECTION 110
105 CELLULITIS 109
106 HEPATIC ENZYME INCREASED 109
107 ASPARTATE AMINOTRANSFERASE INCREASED 108
108 BLOOD BILIRUBIN INCREASED 108
109 NO ADVERSE EVENT 108
110 TUMOUR LYSIS SYNDROME 107
111 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 106
112 MYALGIA 106
113 DRUG LEVEL INCREASED 105
114 SYSTEMIC CANDIDA 105
115 TREMOR 105
116 DRUG INTOLERANCE 104
117 LEUKOPENIA 103
118 SOMNOLENCE 103
119 CHRONIC GRAFT VERSUS HOST DISEASE 102
120 PERICARDIAL EFFUSION 102
121 GASTROINTESTINAL HAEMORRHAGE 101
122 MYOSITIS 101
123 PULMONARY EMBOLISM 101
124 INCORRECT DOSE ADMINISTERED 100
125 ERYTHEMA 99
126 HEPATIC FAILURE 99
127 HYPOMAGNESAEMIA 99
128 ENTEROCOCCAL INFECTION 98
129 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 98
130 ALOPECIA 97
131 HALLUCINATION 97
132 HEPATOCELLULAR INJURY 97
133 PSEUDOALDOSTERONISM 97
134 CARDIAC FAILURE 96
135 DEHYDRATION 96
136 GRAFT VERSUS HOST DISEASE IN SKIN 96
137 CHEST PAIN 95
138 ACUTE RESPIRATORY DISTRESS SYNDROME 92
139 BACK PAIN 92
140 LABELLED DRUG-DRUG INTERACTION ISSUE 92
141 THROMBOTIC MICROANGIOPATHY 92
142 BRADYCARDIA 91
143 BLOOD ALKALINE PHOSPHATASE INCREASED 89
144 PATHOGEN RESISTANCE 89
145 CARDIAC FAILURE CONGESTIVE 87
146 EPISTAXIS 87
147 PERIPHERAL SWELLING 87
148 TRANSAMINASES INCREASED 87
149 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86
150 HEPATIC FUNCTION ABNORMAL 85
151 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 85
152 NEPHROPATHY TOXIC 84
153 SINUSITIS 84
154 SCEDOSPORIUM INFECTION 83
155 VISUAL IMPAIRMENT 83
156 BK VIRUS INFECTION 81
157 DRUG LEVEL DECREASED 81
158 LUNG DISORDER 81
159 OEDEMA 81
160 PAIN IN EXTREMITY 81
161 OVERDOSE 80
162 SEIZURE 80
163 STAPHYLOCOCCAL BACTERAEMIA 80
164 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 79
165 GASTROINTESTINAL DISORDER 78
166 AGRANULOCYTOSIS 77
167 INTENTIONAL PRODUCT USE ISSUE 76
168 C-REACTIVE PROTEIN INCREASED 75
169 RED BLOOD CELL COUNT DECREASED 75
170 RESPIRATORY DISTRESS 75
171 SYSTEMIC MYCOSIS 75
172 INFLUENZA 72
173 LIVER FUNCTION TEST ABNORMAL 72
174 MENTAL STATUS CHANGES 72
175 ACUTE RESPIRATORY FAILURE 71
176 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 71
177 COLITIS 70
178 HAEMOPTYSIS 70
179 PULMONARY OEDEMA 70
180 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 69
181 INSOMNIA 69
182 MULTI-ORGAN FAILURE 69
183 RHABDOMYOLYSIS 69
184 ABDOMINAL DISTENSION 68
185 SYNCOPE 68
186 DEEP VEIN THROMBOSIS 67
187 LEUKAEMIA 67
188 ASCITES 66
189 BLOOD LACTATE DEHYDROGENASE INCREASED 66
190 HOSPICE CARE 66
191 LYMPHOPENIA 66
192 DIFFERENTIATION SYNDROME 65
193 DISEASE RECURRENCE 65
194 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 64
195 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 64
196 TORSADE DE POINTES 64
197 VENOOCCLUSIVE LIVER DISEASE 64
198 WEIGHT INCREASED 63
199 ABDOMINAL PAIN UPPER 62
200 ANXIETY 62
201 FUNGAEMIA 62
202 LOSS OF CONSCIOUSNESS 62
203 ABDOMINAL DISCOMFORT 61
204 GAIT DISTURBANCE 61
205 KLEBSIELLA INFECTION 61
206 RENAL DISORDER 61
207 CEREBRAL HAEMORRHAGE 60
208 PULMONARY MASS 60
209 CLOSTRIDIUM DIFFICILE COLITIS 59
210 DELIRIUM 59
211 MYELODYSPLASTIC SYNDROME 59
212 SKIN LESION 59
213 CYTOMEGALOVIRUS VIRAEMIA 58
214 LIVER DISORDER 58
215 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58
216 CHEST DISCOMFORT 57
217 HYPERKALAEMIA 57
218 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 57
219 THERAPY NON-RESPONDER 57
220 ACUTE GRAFT VERSUS HOST DISEASE 56
221 LIVER INJURY 56
222 PANCREATITIS ACUTE 56
223 DISSEMINATED INTRAVASCULAR COAGULATION 55
224 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 55
225 BRAIN ABSCESS 54
226 CLOSTRIDIUM DIFFICILE INFECTION 54
227 SKIN EXFOLIATION 54
228 FULL BLOOD COUNT DECREASED 53
229 LEUKOCYTOSIS 53
230 NEUTROPENIC SEPSIS 53
231 RESPIRATORY DISORDER 53
232 STOMATITIS 53
233 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 52
234 HERPES SIMPLEX 52
235 HYPOGAMMAGLOBULINAEMIA 52
236 LUNG INFILTRATION 52
237 BRAIN OEDEMA 51
238 DEPRESSED LEVEL OF CONSCIOUSNESS 51
239 DYSPHAGIA 51
240 MALIGNANT NEOPLASM PROGRESSION 51
241 STAPHYLOCOCCAL SEPSIS 51
242 VISION BLURRED 51
243 HAEMATURIA 50
244 HYPERGLYCAEMIA 50
245 HYPOPHOSPHATAEMIA 50
246 MICROSPORIDIA INFECTION 50
247 COMA 49
248 ELECTROLYTE IMBALANCE 49
249 ESCHERICHIA BACTERAEMIA 49
250 INTERSTITIAL LUNG DISEASE 49
251 VIRAL INFECTION 49
252 ARRHYTHMIA 48
253 CYSTITIS HAEMORRHAGIC 48
254 EPSTEIN-BARR VIRUS INFECTION 48
255 PANCREATITIS 48
256 PARAESTHESIA 48
257 CONTUSION 47
258 DRUG ERUPTION 47
259 HYPOPHAGIA 47
260 ILEUS PARALYTIC 47
261 OXYGEN SATURATION DECREASED 47
262 RENAL FAILURE ACUTE 47
263 CENTRAL NERVOUS SYSTEM LESION 46
264 HEPATITIS 46
265 IMMUNODEFICIENCY 46
266 METABOLIC ACIDOSIS 46
267 RESPIRATORY SYNCYTIAL VIRUS INFECTION 46
268 TOXIC EPIDERMAL NECROLYSIS 46
269 HALLUCINATION, VISUAL 45
270 LUNG INFECTION 45
271 PNEUMONITIS 45
272 RESPIRATORY TRACT INFECTION 45
273 ENTEROCOLITIS 44
274 ESCHERICHIA INFECTION 44
275 FEELING ABNORMAL 44
276 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44
277 PARAINFLUENZAE VIRUS INFECTION 44
278 BLOOD POTASSIUM DECREASED 43
279 FLUID RETENTION 43
280 ORAL HERPES 43
281 PULMONARY MUCORMYCOSIS 43
282 THROMBOSIS 43
283 ADENOVIRUS INFECTION 42
284 DRUG DOSE OMISSION 42
285 DRUG HYPERSENSITIVITY 42
286 HAEMATOLOGICAL INFECTION 42
287 LIVER FUNCTION TEST INCREASED 42
288 NEUTROPENIC COLITIS 42
289 WHITE BLOOD CELL COUNT INCREASED 42
290 BALANCE DISORDER 41
291 CARDIO-RESPIRATORY ARREST 41
292 JAUNDICE 41
293 MYOCARDIAL INFARCTION 41
294 TRANSFUSION 41
295 ACUTE PULMONARY OEDEMA 40
296 LETHARGY 40
297 MUSCLE SPASMS 40
298 PNEUMONIA BACTERIAL 40
299 TRANSPLANT REJECTION 40
300 ACUTE LYMPHOCYTIC LEUKAEMIA 39
301 BONE PAIN 39
302 CEREBRAL ASPERGILLOSIS 39
303 GENERALISED OEDEMA 39
304 HAEMATOCRIT DECREASED 39
305 HYPOAESTHESIA 39
306 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 39
307 APLASTIC ANAEMIA 38
308 DRY EYE 38
309 EJECTION FRACTION DECREASED 38
310 FEBRILE BONE MARROW APLASIA 38
311 ILEUS 38
312 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38
313 INFLAMMATION 38
314 SKIN NECROSIS 38
315 URTICARIA 38
316 VENTRICULAR TACHYCARDIA 38
317 ADRENAL INSUFFICIENCY 37
318 AGITATION 37
319 BACTERIAL SEPSIS 37
320 BLOOD COUNT ABNORMAL 37
321 BLOOD GLUCOSE INCREASED 37
322 DRY SKIN 37
323 ENTEROCOCCAL BACTERAEMIA 37
324 IMMUNOSUPPRESSION 37
325 PRODUCTIVE COUGH 37
326 CATARACT 36
327 GRAFT VERSUS HOST DISEASE IN LIVER 36
328 MALNUTRITION 36
329 MOUTH ULCERATION 36
330 NERVOUS SYSTEM DISORDER 36
331 RENAL TUBULAR NECROSIS 36
332 SINUS BRADYCARDIA 36
333 DYSPNOEA EXERTIONAL 35
334 HEPATOMEGALY 35
335 ILLNESS 35
336 LEUKAEMIA RECURRENT 35
337 LYMPHADENOPATHY 35
338 MEMORY IMPAIRMENT 35
339 NOCARDIOSIS 35
340 PNEUMOCYSTIS JIROVECII PNEUMONIA 35
341 THERAPEUTIC RESPONSE DECREASED 35
342 TOXIC SKIN ERUPTION 35
343 UPPER RESPIRATORY TRACT INFECTION 35
344 BLOOD PRESSURE INCREASED 34
345 CEREBRAL TOXOPLASMOSIS 34
346 DISORIENTATION 34
347 DRY MOUTH 34
348 ENDOPHTHALMITIS 34
349 ESCHERICHIA SEPSIS 34
350 HYPOCALCAEMIA 34
351 KLEBSIELLA BACTERAEMIA 34
352 LABORATORY TEST ABNORMAL 34
353 LACTIC ACIDOSIS 34
354 LEUKOENCEPHALOPATHY 34
355 POLYMYOSITIS 34
356 PROTOTHECOSIS 34
357 RASH PRURITIC 34
358 APHASIA 33
359 JOINT SWELLING 33
360 MOBILITY DECREASED 33
361 PERIPHERAL SENSORY NEUROPATHY 33
362 PSEUDOMONAL SEPSIS 33
363 SWELLING 33
364 APLASIA 32
365 COAGULOPATHY 32
366 CONVULSION 32
367 DIABETES MELLITUS 32
368 DYSPEPSIA 32
369 HEPATIC NECROSIS 32
370 HYPERSENSITIVITY 32
371 MUSCULOSKELETAL STIFFNESS 32
372 NASOPHARYNGITIS 32
373 NEOPLASM MALIGNANT 32
374 NEOPLASM PROGRESSION 32
375 PRODUCT DOSE OMISSION 32
376 STEM CELL TRANSPLANT 32
377 STENOTROPHOMONAS INFECTION 32
378 VENTRICULAR FIBRILLATION 32
379 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 31
380 BRAIN HERNIATION 31
381 ENTERITIS 31
382 FACE OEDEMA 31
383 GASTROINTESTINAL TOXICITY 31
384 HYPOALBUMINAEMIA 31
385 MELAENA 31
386 PHAEOHYPHOMYCOSIS 31
387 PULMONARY HAEMORRHAGE 31
388 RHINOVIRUS INFECTION 31
389 SUBDURAL HAEMATOMA 31
390 TASTE DISORDER 31
391 ABSCESS 30
392 ADVERSE DRUG REACTION 30
393 CARDIAC DISORDER 30
394 CARDIOACTIVE DRUG LEVEL INCREASED 30
395 CYSTITIS 30
396 DEPRESSION 30
397 HEART RATE INCREASED 30
398 MUSCULOSKELETAL PAIN 30
399 ORAL DISORDER 30
400 PLATELET TRANSFUSION 30
401 RENAL TUBULAR DISORDER 30
402 SEPTIC EMBOLUS 30
403 SINUSITIS FUNGAL 30
404 SKIN INFECTION 30
405 SOFT TISSUE INFECTION 30
406 STEVENS-JOHNSON SYNDROME 30
407 UNEVALUABLE EVENT 30
408 VASCULITIS 30
409 ANTIBIOTIC LEVEL BELOW THERAPEUTIC 29
410 BLOOD IMMUNOGLOBULIN G DECREASED 29
411 BRAIN FOG 29
412 CONTRAINDICATED PRODUCT ADMINISTERED 29
413 COVID-19 PNEUMONIA 29
414 DRUG LEVEL ABOVE THERAPEUTIC 29
415 GEOTRICHUM INFECTION 29
416 INFUSION RELATED REACTION 29
417 KLEBSIELLA SEPSIS 29
418 LOWER RESPIRATORY TRACT INFECTION 29
419 ORAL CANDIDIASIS 29
420 OROPHARYNGEAL PAIN 29
421 OSTEOPOROSIS 29
422 PHOTOSENSITIVITY REACTION 29
423 CARDIOMYOPATHY 28
424 CIRCULATORY COLLAPSE 28
425 EYE INFECTION FUNGAL 28
426 FLUID OVERLOAD 28
427 GINGIVAL BLEEDING 28
428 HAEMORRHOIDS 28
429 ORGANISING PNEUMONIA 28
430 RASH ERYTHEMATOUS 28
431 RENAL INJURY 28
432 TREATMENT NONCOMPLIANCE 28
433 TYPE 2 DIABETES MELLITUS 28
434 URINARY RETENTION 28
435 ASPERGILLOSIS 27
436 BLINDNESS 27
437 BLISTER 27
438 BRONCHITIS 27
439 CHOLECYSTITIS ACUTE 27
440 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 27
441 DYSGEUSIA 27
442 LUNG CONSOLIDATION 27
443 LUNG OPACITY 27
444 PNEUMONIA KLEBSIELLA 27
445 SHOCK 27
446 ATRIOVENTRICULAR BLOCK SECOND DEGREE 26
447 BILIRUBIN CONJUGATED INCREASED 26
448 BLOOD UREA INCREASED 26
449 BONE MARROW TRANSPLANT 26
450 EPILEPSY 26
451 GRAFT VERSUS HOST DISEASE IN LUNG 26
452 HEPATITIS CHOLESTATIC 26
453 PLASMA CELL MYELOMA 26
454 PRODUCT PRESCRIBING ISSUE 26
455 PULMONARY ALVEOLAR HAEMORRHAGE 26
456 ATYPICAL PNEUMONIA 25
457 DRUG EFFECT INCOMPLETE 25
458 ENCEPHALITIS 25
459 ENDOCARDITIS 25
460 FUNGAL SKIN INFECTION 25
461 HAEMODYNAMIC INSTABILITY 25
462 HERPES ZOSTER 25
463 NEUTROPENIC INFECTION 25
464 PRESYNCOPE 25
465 RETINAL HAEMORRHAGE 25
466 SKIN DISCOLOURATION 25
467 SWELLING FACE 25
468 TACHYPNOEA 25
469 TRANSPLANT 25
470 CARDIOGENIC SHOCK 24
471 CEREBROVASCULAR ACCIDENT 24
472 ENTEROBACTER BACTERAEMIA 24
473 EYE PAIN 24
474 LONG QT SYNDROME 24
475 LYMPHOCYTE COUNT DECREASED 24
476 NODULE 24
477 PALPITATIONS 24
478 POLYNEUROPATHY 24
479 PRODUCT AVAILABILITY ISSUE 24
480 SINUS TACHYCARDIA 24
481 SKIN DISORDER 24
482 SPLENOMEGALY 24
483 VIRAL HAEMORRHAGIC CYSTITIS 24
484 ACANTHAMOEBA INFECTION 23
485 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 23
486 BICYTOPENIA 23
487 BONE MARROW DISORDER 23
488 COGNITIVE DISORDER 23
489 DIVERTICULITIS 23
490 FOLLICULITIS 23
491 FULL BLOOD COUNT ABNORMAL 23
492 HYPERLEUKOCYTOSIS 23
493 HYPERTRANSAMINASAEMIA 23
494 ORTHOSTATIC HYPOTENSION 23
495 PETECHIAE 23
496 PRIMARY ADRENAL INSUFFICIENCY 23
497 PURPURA 23
498 RHINOCEREBRAL MUCORMYCOSIS 23
499 SERUM FERRITIN INCREASED 23
500 SHOCK HAEMORRHAGIC 23
501 SKIN ULCER 23
502 UNDERDOSE 23
503 VASCULAR DEVICE INFECTION 23
504 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 22
505 ATELECTASIS 22
506 BLOOD ALBUMIN DECREASED 22
507 BLOOD MAGNESIUM DECREASED 22
508 BODY TEMPERATURE INCREASED 22
509 CAPILLARY LEAK SYNDROME 22
510 CARDIAC FAILURE ACUTE 22
511 CELL DEATH 22
512 CHOROIDAL EFFUSION 22
513 CHRONIC KIDNEY DISEASE 22
514 CYTOLYTIC HEPATITIS 22
515 HAEMATOMA 22
516 LOCALISED INFECTION 22
517 LOWER RESPIRATORY TRACT INFECTION FUNGAL 22
518 MALABSORPTION 22
519 MENTAL DISORDER 22
520 MYOPATHY 22
521 NEUROLOGICAL SYMPTOM 22
522 OLIGURIA 22
523 PAPULE 22
524 PNEUMONIA PSEUDOMONAL 22
525 RECTAL HAEMORRHAGE 22
526 RENAL TUBULAR ACIDOSIS 22
527 STEROID DIABETES 22
528 THERAPY PARTIAL RESPONDER 22
529 ZYGOMYCOSIS 22
530 ACUTE HEPATIC FAILURE 21
531 ASPIRATION 21
532 BLOOD PRESSURE ABNORMAL 21
533 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 21
534 DECUBITUS ULCER 21
535 ECZEMA 21
536 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 21
537 FLUSHING 21
538 GASTROOESOPHAGEAL REFLUX DISEASE 21
539 OBSTRUCTIVE AIRWAYS DISORDER 21
540 ORGAN FAILURE 21
541 PRODUCT QUALITY ISSUE 21
542 RHINORRHOEA 21
543 ACUTE MYOCARDIAL INFARCTION 20
544 ADENOVIRUS REACTIVATION 20
545 ALTERED STATE OF CONSCIOUSNESS 20
546 ANGLE CLOSURE GLAUCOMA 20
547 ASTHMA 20
548 CHOLELITHIASIS 20
549 GASTROINTESTINAL INFECTION 20
550 GRAFT COMPLICATION 20
551 HAEMATEMESIS 20
552 HAEMATOCHEZIA 20
553 HYPERTHERMIA 20
554 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20
555 LEFT VENTRICULAR DYSFUNCTION 20
556 NEURALGIA 20
557 PNEUMOTHORAX 20
558 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20
559 PSEUDOMONAL BACTERAEMIA 20
560 STATUS EPILEPTICUS 20
561 UNRESPONSIVE TO STIMULI 20
562 ANURIA 19
563 BLOOD CREATINE PHOSPHOKINASE INCREASED 19
564 BLOOD PRESSURE DECREASED 19
565 CYSTITIS VIRAL 19
566 DEMODICIDOSIS 19
567 DERMATITIS EXFOLIATIVE GENERALISED 19
568 FAILURE TO THRIVE 19
569 HAEMATOTOXICITY 19
570 MEDICATION ERROR 19
571 MITRAL VALVE INCOMPETENCE 19
572 MIXED LIVER INJURY 19
573 MUSCLE ATROPHY 19
574 PERICARDITIS 19
575 ATAXIA 18
576 BRONCHIOLITIS OBLITERANS SYNDROME 18
577 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18
578 CYTOMEGALOVIRUS TEST POSITIVE 18
579 DISTURBANCE IN ATTENTION 18
580 HAEMOLYSIS 18
581 HAEMORRHAGE INTRACRANIAL 18
582 HEMIPARESIS 18
583 HEPATITIS FULMINANT 18
584 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18
585 INTESTINAL HAEMORRHAGE 18
586 LARGE INTESTINE PERFORATION 18
587 METHAEMOGLOBINAEMIA 18
588 MYOCARDITIS 18
589 ORAL PAIN 18
590 PNEUMONIA CYTOMEGALOVIRAL 18
591 SKIN MASS 18
592 STUPOR 18
593 TUBULOINTERSTITIAL NEPHRITIS 18
594 WHEEZING 18
595 ACQUIRED APPARENT MINERALOCORTICOID EXCESS 17
596 ADENOVIRAL HEPATITIS 17
597 ALLOGENIC STEM CELL TRANSPLANTATION 17
598 BLOOD SODIUM DECREASED 17
599 BOWEN^S DISEASE 17
600 CARDIAC DYSFUNCTION 17
601 CARDIAC TAMPONADE 17
602 CATHETER SITE INFECTION 17
603 CHOLECYSTITIS 17
604 CONGENITAL APLASIA 17
605 DISSEMINATED MUCORMYCOSIS 17
606 DYSURIA 17
607 EOSINOPHILIA 17
608 HEPATIC LESION 17
609 HERPES SIMPLEX REACTIVATION 17
610 HYPERCALCAEMIA 17
611 HYPERVOLAEMIA 17
612 HYPOFIBRINOGENAEMIA 17
613 HYPOGLYCAEMIA 17
614 HYPOTHERMIA 17
615 IMPAIRED HEALING 17
616 JAUNDICE CHOLESTATIC 17
617 LUNG TRANSPLANT 17
618 MULTIPLE-DRUG RESISTANCE 17
619 NO THERAPEUTIC RESPONSE 17
620 OPTIC NEUROPATHY 17
621 PALLOR 17
622 PARONYCHIA 17
623 PROCTALGIA 17
624 PULMONARY ARTERIAL HYPERTENSION 17
625 RED CELL DISTRIBUTION WIDTH INCREASED 17
626 SQUAMOUS CELL CARCINOMA 17
627 SQUAMOUS CELL CARCINOMA OF SKIN 17
628 THERAPY CESSATION 17
629 TINNITUS 17
630 TOXIC ENCEPHALOPATHY 17
631 ANAL ABSCESS 16
632 ANTICOAGULATION DRUG LEVEL INCREASED 16
633 BLAST CELL COUNT INCREASED 16
634 BLOOD CALCIUM DECREASED 16
635 CACHEXIA 16
636 CEREBRAL HAEMATOMA 16
637 CHROMATURIA 16
638 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 16
639 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 16
640 COCCIDIOIDOMYCOSIS 16
641 DYSPHONIA 16
642 ENTEROBACTER INFECTION 16
643 ENTEROCOCCAL SEPSIS 16
644 FLATULENCE 16
645 GASTRIC ULCER 16
646 HEPATIC STEATOSIS 16
647 HEPATITIS ACUTE 16
648 HYPERNATRAEMIA 16
649 ISCHAEMIC STROKE 16
650 LIPASE INCREASED 16
651 LOWER GASTROINTESTINAL HAEMORRHAGE 16
652 MYOPERICARDITIS 16
653 NECROTISING RETINITIS 16
654 OSTEOMYELITIS 16
655 OSTEONECROSIS 16
656 PELVIC VENOUS THROMBOSIS 16
657 PNEUMONIA ASPIRATION 16
658 PULMONARY HYPERTENSION 16
659 PULMONARY NOCARDIOSIS 16
660 RASH MACULAR 16
661 RESPIRATORY TRACT INFECTION FUNGAL 16
662 SECONDARY ADRENOCORTICAL INSUFFICIENCY 16
663 VENTRICULAR EXTRASYSTOLES 16
664 VERTIGO 16
665 ACNE 15
666 AGEUSIA 15
667 ARTHRITIS 15
668 ATRIOVENTRICULAR BLOCK 15
669 BLOOD TEST ABNORMAL 15
670 CEREBRAL ARTERY EMBOLISM 15
671 CEREBRAL INFARCTION 15
672 CUSHINGOID 15
673 DEPRESSED MOOD 15
674 DERMATITIS EXFOLIATIVE 15
675 ECTHYMA 15
676 EXTREMITY NECROSIS 15
677 GENERALISED TONIC-CLONIC SEIZURE 15
678 HAEMOLYTIC ANAEMIA 15
679 HYPERHIDROSIS 15
680 ILL-DEFINED DISORDER 15
681 INFECTION REACTIVATION 15
682 INFECTIOUS PLEURAL EFFUSION 15
683 INTENTIONAL PRODUCT MISUSE 15
684 MENINGITIS 15
685 NECROSIS 15
686 NEOPLASM 15
687 NEPHROGENIC DIABETES INSIPIDUS 15
688 NIGHT SWEATS 15
689 POTENTIATING DRUG INTERACTION 15
690 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 15
691 SERUM SICKNESS 15
692 SINOATRIAL BLOCK 15
693 SLEEP DISORDER 15
694 STREPTOCOCCAL BACTERAEMIA 15
695 SUICIDAL IDEATION 15
696 TONGUE ULCERATION 15
697 UPPER GASTROINTESTINAL HAEMORRHAGE 15
698 VENOOCCLUSIVE DISEASE 15
699 ACUTE LEUKAEMIA 14
700 AMNESIA 14
701 ANAPHYLACTIC REACTION 14
702 ANGINA PECTORIS 14
703 CATATONIA 14
704 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14
705 COAGULATION TEST ABNORMAL 14
706 CYTOMEGALOVIRUS COLITIS 14
707 DIFFUSE LARGE B-CELL LYMPHOMA 14
708 DIZZINESS POSTURAL 14
709 FEEDING DISORDER 14
710 FEMUR FRACTURE 14
711 HYPERAMMONAEMIA 14
712 HYPERTRIGLYCERIDAEMIA 14
713 INTESTINAL PERFORATION 14
714 INTRACRANIAL MASS 14
715 JUGULAR VEIN THROMBOSIS 14
716 LIVER ABSCESS 14
717 LUNG TRANSPLANT REJECTION 14
718 METAPNEUMOVIRUS INFECTION 14
719 MYCOBACTERIUM AVIUM COMPLEX INFECTION 14
720 MYOCARDIAL ISCHAEMIA 14
721 OESOPHAGITIS 14
722 PROCTITIS 14
723 PROTEINURIA 14
724 PULMONARY SEPSIS 14
725 RESPIRATORY ARREST 14
726 RETINAL ISCHAEMIA 14
727 RHINITIS 14
728 SINUSITIS BACTERIAL 14
729 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14
730 THERAPY INTERRUPTED 14
731 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 14
732 TROPONIN INCREASED 14
733 UREAPLASMA INFECTION 14
734 ABDOMINAL TENDERNESS 13
735 ACUTE MYELOID LEUKAEMIA REFRACTORY 13
736 ANGIOEDEMA 13
737 ASPERGILLUS TEST POSITIVE 13
738 CANDIDIASIS 13
739 CARDIAC VALVE VEGETATION 13
740 CENTRAL NERVOUS SYSTEM INFECTION 13
741 COLITIS ULCERATIVE 13
742 DEVICE RELATED SEPSIS 13
743 DIPLOPIA 13
744 DISSEMINATED TOXOPLASMOSIS 13
745 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13
746 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 13
747 EMPHYSEMA 13
748 EYE SWELLING 13
749 HEAD INJURY 13
750 HEPATITIS TOXIC 13
751 HEPATOSPLENIC CANDIDIASIS 13
752 HUMAN HERPESVIRUS 6 INFECTION 13
753 HYDRONEPHROSIS 13
754 HYPERPYREXIA 13
755 INFLUENZA LIKE ILLNESS 13
756 INTERNAL HAEMORRHAGE 13
757 METABOLIC ENCEPHALOPATHY 13
758 MONOCYTE COUNT INCREASED 13
759 MYCOBACTERIUM ABSCESSUS INFECTION 13
760 NASAL CONGESTION 13
761 NEPHROLITHIASIS 13
762 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13
763 PERIPHERAL VENOUS DISEASE 13
764 PERITONITIS 13
765 PLATELET COUNT ABNORMAL 13
766 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 13
767 POST PROCEDURAL COMPLICATION 13
768 PRODUCT DISTRIBUTION ISSUE 13
769 PRODUCT PRESCRIBING ERROR 13
770 PSYCHOTIC DISORDER 13
771 PULMONARY FUNCTION TEST DECREASED 13
772 SKIN CANCER 13
773 SUBARACHNOID HAEMORRHAGE 13
774 TRANSPLANT FAILURE 13
775 TRICUSPID VALVE INCOMPETENCE 13
776 ACIDOSIS 12
777 AMYLASE INCREASED 12
778 ANAL INCONTINENCE 12
779 BLOOD DISORDER 12
780 BLOOD POTASSIUM INCREASED 12
781 BRONCHOPNEUMONIA 12
782 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 12
783 CHRONIC LYMPHOCYTIC LEUKAEMIA 12
784 CITROBACTER INFECTION 12
785 DEAFNESS 12
786 DERMATITIS 12
787 DRUG ADMINISTRATION ERROR 12
788 DYSARTHRIA 12
789 ELECTROCARDIOGRAM PR SHORTENED 12
790 ENTEROBACTER TEST POSITIVE 12
791 EPSTEIN-BARR VIRAEMIA 12
792 ESCHERICHIA URINARY TRACT INFECTION 12
793 FUNGAL SEPSIS 12
794 HAEMOGLOBIN ABNORMAL 12
795 HEPATIC ENCEPHALOPATHY 12
796 HEPATIC ENZYME ABNORMAL 12
797 HYPERAMMONAEMIC ENCEPHALOPATHY 12
798 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12
799 ISCHAEMIC CARDIOMYOPATHY 12
800 LUNG ABSCESS 12
801 MYCOTIC ENDOPHTHALMITIS 12
802 NECK PAIN 12
803 PHARYNGITIS 12
804 POLYURIA 12
805 PRESCRIBED OVERDOSE 12
806 PULMONARY MYCOSIS 12
807 SKIN HYPERPIGMENTATION 12
808 SMALL INTESTINAL OBSTRUCTION 12
809 SUDDEN DEATH 12
810 TENDONITIS 12
811 TRANSPLANTATION COMPLICATION 12
812 URINARY INCONTINENCE 12
813 VISUAL ACUITY REDUCED 12
814 ACCIDENTAL OVERDOSE 11
815 APPENDICITIS 11
816 ARTHRITIS BACTERIAL 11
817 AZOTAEMIA 11
818 BLOOD CREATININE ABNORMAL 11
819 BLOOD PHOSPHORUS DECREASED 11
820 BRAIN INJURY 11
821 BRONCHOSPASM 11
822 CANDIDA SEPSIS 11
823 CARDIOVASCULAR DISORDER 11
824 CHIMERISM 11
825 CONJUNCTIVITIS 11
826 CUTANEOUS MUCORMYCOSIS 11
827 CYSTIC FIBROSIS 11
828 CYTOMEGALOVIRUS ENTEROCOLITIS 11
829 DIALYSIS 11
830 DISSEMINATED COCCIDIOIDOMYCOSIS 11
831 ENCEPHALITIS VIRAL 11
832 ENDOTRACHEAL INTUBATION 11
833 ENGRAFTMENT SYNDROME 11
834 EYE DISORDER 11
835 FAECES DISCOLOURED 11
836 FEBRILE INFECTION 11
837 GASTRIC DILATATION 11
838 GASTROENTERITIS 11
839 GASTROINTESTINAL INFLAMMATION 11
840 GASTROINTESTINAL TUBE INSERTION 11
841 GROWTH FAILURE 11
842 HIATUS HERNIA 11
843 HIP FRACTURE 11
844 HYPERTENSIVE CRISIS 11
845 HYPOACUSIS 11
846 HYPOGONADISM 11
847 HYPOVENTILATION 11
848 INHIBITORY DRUG INTERACTION 11
849 INTERNATIONAL NORMALISED RATIO INCREASED 11
850 LEFT ATRIAL HYPERTROPHY 11
851 LIP SQUAMOUS CELL CARCINOMA 11
852 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11
853 MIGRAINE 11
854 NEPHROTIC SYNDROME 11
855 NEUROLOGICAL DECOMPENSATION 11
856 NPM1 GENE MUTATION 11
857 OBLITERATIVE BRONCHIOLITIS 11
858 PLATELET COUNT INCREASED 11
859 PRODUCT DEPOSIT 11
860 PROTEIN TOTAL DECREASED 11
861 PURULENT DISCHARGE 11
862 RALES 11
863 RASH PAPULAR 11
864 RETCHING 11
865 RIB FRACTURE 11
866 SCAB 11
867 SCLERODERMA 11
868 SINUS DISORDER 11
869 SUPRAVENTRICULAR TACHYCARDIA 11
870 SUSPECTED OFF LABEL USE 11
871 URINE OUTPUT DECREASED 11
872 VARICELLA ZOSTER VIRUS INFECTION 11
873 ABSCESS FUNGAL 10
874 ABSCESS LIMB 10
875 ACUTE CORONARY SYNDROME 10
876 APLASIA PURE RED CELL 10
877 AREFLEXIA 10
878 ATRIAL FLUTTER 10
879 AXONAL NEUROPATHY 10
880 BLINDNESS UNILATERAL 10
881 BLOOD URIC ACID INCREASED 10
882 BONE DENSITY DECREASED 10
883 BONE MARROW TOXICITY 10
884 CENTRAL VENOUS CATHETERISATION 10
885 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 10
886 CONJUNCTIVAL HAEMORRHAGE 10
887 CORONAVIRUS INFECTION 10
888 CORYNEBACTERIUM BACTERAEMIA 10
889 CUSHING^S SYNDROME 10
890 CYTOMEGALOVIRUS CHORIORETINITIS 10
891 DIASTOLIC DYSFUNCTION 10
892 DRUG TOXICITY 10
893 ECCHYMOSIS 10
894 ENCEPHALITIS FUNGAL 10
895 ENTEROBACTER SEPSIS 10
896 ERYTHEMA MULTIFORME 10
897 ESCHERICHIA TEST POSITIVE 10
898 FAECES SOFT 10
899 GASTRITIS 10
900 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10
901 GLUCOCORTICOID DEFICIENCY 10
902 GUILLAIN-BARRE SYNDROME 10
903 HAEMOLYTIC URAEMIC SYNDROME 10
904 HALLUCINATIONS, MIXED 10
905 HERPES VIRUS INFECTION 10
906 INTRAOCULAR PRESSURE TEST 10
907 IRRITABILITY 10
908 LACRIMATION INCREASED 10
909 MAJOR DEPRESSION 10
910 MALIGNANT MELANOMA 10
911 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 10
912 MUSCULOSKELETAL DISORDER 10
913 NEUTROPHIL COUNT ABNORMAL 10
914 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 10
915 OCULAR ICTERUS 10
916 ODYNOPHAGIA 10
917 OSTEOARTHRITIS 10
918 PAIN IN JAW 10
919 PARALYSIS 10
920 PERIORBITAL OEDEMA 10
921 PHOTOPHOBIA 10
922 PLASMA CELL MYELOMA REFRACTORY 10
923 POLLAKIURIA 10
924 PRODUCT DOSE OMISSION IN ERROR 10
925 PULSELESS ELECTRICAL ACTIVITY 10
926 STRESS 10
927 THERAPEUTIC RESPONSE UNEXPECTED 10
928 THROMBOTIC THROMBOCYTOPENIC PURPURA 10
929 TRANSIENT ISCHAEMIC ATTACK 10
930 VITAMIN B12 DECREASED 10
931 WHITE BLOOD CELL COUNT ABNORMAL 10
932 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9
933 ANAL FISTULA 9
934 ARTHROPATHY 9
935 BK POLYOMAVIRUS TEST POSITIVE 9
936 BLOOD CHOLESTEROL INCREASED 9
937 BLOOD TRIGLYCERIDES INCREASED 9
938 CEREBRAL VENTRICLE COLLAPSE 9
939 CHEMOTHERAPY 9
940 CHRONIC GASTRITIS 9
941 DISINHIBITION 9
942 EXOPHTHALMOS 9
943 FEELING COLD 9
944 FEELING HOT 9
945 GASTROINTESTINAL MUCORMYCOSIS 9
946 GINGIVAL PAIN 9
947 GRAFT VERSUS HOST DISEASE IN INTESTINE 9
948 HYPERSOMNIA 9
949 IDIOPATHIC PNEUMONIA SYNDROME 9
950 IMMUNE THROMBOCYTOPENIA 9
951 INCORRECT DOSAGE ADMINISTERED 9
952 INCORRECT PRODUCT ADMINISTRATION DURATION 9
953 INFECTIVE ANEURYSM 9
954 INFLAMMATORY MARKER INCREASED 9
955 INSURANCE ISSUE 9
956 INTESTINAL ISCHAEMIA 9
957 IRIDOCYCLITIS 9
958 JC VIRUS INFECTION 9
959 JOINT EFFUSION 9
960 MINIMAL RESIDUAL DISEASE 9
961 MUSCLE NECROSIS 9
962 MUSCULOSKELETAL CHEST PAIN 9
963 MYCETOMA MYCOTIC 9
964 MYCOBACTERIAL INFECTION 9
965 MYDRIASIS 9
966 MYOCARDIAL NECROSIS MARKER INCREASED 9
967 OCULAR HYPERAEMIA 9
968 OESOPHAGITIS ULCERATIVE 9
969 OTOTOXICITY 9
970 OVERGROWTH FUNGAL 9
971 PARTIAL SEIZURES 9
972 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 9
973 PRODUCT DISPENSING ERROR 9
974 PROTHROMBIN TIME PROLONGED 9
975 PULMONARY THROMBOSIS 9
976 SKIN ATROPHY 9
977 SKIN HAEMORRHAGE 9
978 SPEECH DISORDER 9
979 SUBCUTANEOUS ABSCESS 9
980 SURGERY 9
981 THROMBOCYTOSIS 9
982 TOOTH INFECTION 9
983 VASCULAR PURPURA 9
984 VENOUS HAEMORRHAGE 9
985 VITRITIS 9
986 WOUND INFECTION 9
987 ABNORMAL FAECES 8
988 ACINETOBACTER INFECTION 8
989 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8
990 ADRENAL SUPPRESSION 8
991 ANAEMIA MEGALOBLASTIC 8
992 AORTIC ANEURYSM 8
993 APPARENT MINERALOCORTICOID EXCESS 8
994 BLOOD CULTURE POSITIVE 8
995 BLOOD PHOSPHORUS INCREASED 8
996 BLOOD PRESSURE FLUCTUATION 8
997 BONE DISORDER 8
998 BRAIN COMPRESSION 8
999 BRAIN NATRIURETIC PEPTIDE INCREASED 8